Gainers
- Regenxbio RGNX stock increased by 16.6% to $10.4 during Wednesday's pre-market session. The market value of their outstanding shares is at $514.0 million. As per the press release, Q3 earnings came out today.
- Tango Therapeutics TNGX shares increased by 15.83% to $6.0. The market value of their outstanding shares is at $642.8 million.
- Macrogenics MGNX shares increased by 15.11% to $4.34. The company's market cap stands at $272.2 million. As per the news, the Q3 earnings report came out yesterday.
- Xylo Technologies XYLO stock rose 14.4% to $3.97. The market value of their outstanding shares is at $7.5 million.
- Globus Medical GMED shares moved upwards by 13.77% to $85.99. The market value of their outstanding shares is at $11.6 billion. As per the press release, Q3 earnings came out yesterday.
- Processa Pharma PCSA stock increased by 13.63% to $1.25. The company's market cap stands at $4.0 million.
Losers
- Exact Sciences EXAS stock decreased by 26.6% to $52.5 during Wednesday's pre-market session. The company's market cap stands at $9.7 billion. As per the press release, Q3 earnings came out yesterday.
- Bluejay Diagnostics BJDX shares declined by 24.53% to $0.1. The company's market cap stands at $1.7 million.
- Altamira Therapeutics CYTO stock declined by 21.16% to $0.41. The market value of their outstanding shares is at $1.5 million.
- PACS Group PACS shares decreased by 20.49% to $23.49. The market value of their outstanding shares is at $3.6 billion.
- Evotec EVO stock fell 19.66% to $3.68. The company's market cap stands at $1.3 billion. As per the press release, Q3 earnings came out today.
- Bionomics BNOX shares declined by 15.93% to $0.41. The market value of their outstanding shares is at $5.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in